Low plasma levels of miR-101 are associated with tumor progression in gastric cancer

BACKGROUND: Several studies have identified the decreased expression of the tumor suppressor miR-101 in various cancers. In this study, we tested miR-101 as a potential therapeutic target and novel plasma biomarker for gastric cancer (GC). RESULTS: The miR-101 expression level was significantly lowe...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Taisuke, Komatsu, Shuhei, Ichikawa, Daisuke, Miyamae, Mahito, Okajima, Wataru, Ohashi, Takuma, Kiuchi, Jun, Nishibeppu, Keiji, Kosuga, Toshiyuki, Konishi, Hirotaka, Shiozaki, Atsushi, Okamoto, Kazuma, Fujiwara, Hitoshi, Otsuji, Eigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739754/
https://www.ncbi.nlm.nih.gov/pubmed/29290969
http://dx.doi.org/10.18632/oncotarget.20860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739754/
https://www.ncbi.nlm.nih.gov/pubmed/29290969
http://dx.doi.org/10.18632/oncotarget.20860

Ejemplares similares